Like other vaccine developers, the company also is expanding its testing of the vaccine to younger age groups, including children between the ages of 12 to 17.
Tiosan punika, Pemkot Denpasar taler mautsaha mangda negepin rèalisasi vaksinasi majeng i krama, salanturnyanè vaksinasi pacang ngrauhin para sisia sekolahan sanè mayusa 12-17 warsa.